However, upon exclusion of subjects with SLC26A4 mutations from the present cohort, the diagnostic rate of NSHL in the present study decreases to 37.5% (6 of 16 subjects), which is comparable to that reported in the previous study11. This evidence concerns the gene SLC26A4 and nodular sclerosis classical Hodgkin lymphoma.